Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
How will you care for a teenager who intentionally asphyxiated himself and is now unresponsive with agonal respirations?
Last month, state officials updated its policies to allow police, fire and other emergency personnel to carry doses of naloxone nasal spray up to 4 milligrams
Officials announced that the three accidentally overdosed on Ecstasy
The children were taken to a hospital and then into state custody
Our co-hosts are joined by Art Hsieh to discuss an article on carfentanil exposure
The creator hopes the video will raise awareness of the stark realities of overdoses, and will prompt people to seek help in battling their addiction
The state currently only allows paramedics and medical professionals — not EMTs, firefighters or police — to carry the drug.
Official: “It’s so potent that if we come in contact with it, we can get overdose symptoms.”
Unintended or casual exposure to carfentanil, a synthetic opioid 10,000 times more potent than morphine, can be life-threatening
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.